BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32679594)

  • 1. A Pathological Clarification of Sepsis-Associated Disseminated Intravascular Coagulation Based on Comprehensive Coagulation and Fibrinolysis Function.
    Onishi T; Nogami K; Ishihara T; Inoue S; Kawaguchi M; Nishio K; Fukushima H; Kobayashi H; Amano I; Nishikubo T; Yamasaki M; Kasahara M; Shima M
    Thromb Haemost; 2020 Sep; 120(9):1257-1269. PubMed ID: 32679594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation and fibrinolysis balance in disseminated intravascular coagulation.
    Onishi T; Ishihara T; Nogami K
    Pediatr Int; 2021 Nov; 63(11):1311-1318. PubMed ID: 33660897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of emicizumab on in vitro coagulation and fibrinolysis parameters in patients with disseminated intravascular coagulation with and without addition of anti-FVIII antibody.
    Onishi T; Shimo H; Harada S; Nogami K
    Haemophilia; 2024 May; 30(3):836-844. PubMed ID: 38523253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic function in hyperfibrinolytic disseminated intravascular coagulation.
    Ishihara T; Nogami K; Onishi T; Ogiwara K; Ochi S; Yamazaki M; Shima M
    Pediatr Int; 2019 Sep; 61(9):872-881. PubMed ID: 31228869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.
    Hayakawa M; Sawamura A; Gando S; Kubota N; Uegaki S; Shimojima H; Sugano M; Ieko M
    Surgery; 2011 Feb; 149(2):221-30. PubMed ID: 20655560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis.
    Hayakawa M; Sawamura A; Gando S; Jesmin S; Naito S; Ieko M
    Thromb Res; 2012 Dec; 130(6):906-13. PubMed ID: 22353215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders.
    Takahashi H; Tatewaki W; Wada K; Hanano M; Shibata A
    Am J Hematol; 1990 Feb; 33(2):90-5. PubMed ID: 1689102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19.
    Onishi T; Shimonishi N; Takeyama M; Furukawa S; Ogiwara K; Nakajima Y; Kasahara K; Nishio K; Yoshimoto K; Inoue S; Kawaguchi M; Fukushima H; Saito Y; Yoshiji H; Muro S; Tsuruya K; Okada S; Sugie K; Kawaguchi R; Nishikubo T; Yamazaki M; Oda Y; Kawabe T; Onishi K; Nishio T; Nogami K
    Int J Hematol; 2022 Jun; 115(6):826-837. PubMed ID: 35171446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolysis in disseminated intravascular coagulation.
    Hack CE
    Semin Thromb Hemost; 2001 Dec; 27(6):633-8. PubMed ID: 11740686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
    Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
    Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic study before onset of disseminated intravascular coagulation.
    Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi A; Mori Y; Deguchi K
    Am J Hematol; 1993 Jul; 43(3):190-4. PubMed ID: 8352234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
    Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.
    Koyama K; Madoiwa S; Nunomiya S; Koinuma T; Wada M; Sakata A; Ohmori T; Mimuro J; Sakata Y
    Crit Care; 2014 Jan; 18(1):R13. PubMed ID: 24410881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global fibrinolytic capacity in pediatric patients with sepsis and disseminated intravascular coagulation.
    Bay A; Oner AF; Kose D; Dogan M
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):569-73. PubMed ID: 16988553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
    Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro effect of anticoagulant agents on coagulation and fibrinolysis in the presence of emicizumab in the plasmas from patients with haemophilia A.
    Onishi T; Harada S; Shimo H; Tashiro Y; Soeda T; Nogami K
    Haemophilia; 2023 Nov; 29(6):1529-1538. PubMed ID: 37766492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.
    Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A
    Thromb Haemost; 1990 Jun; 63(3):340-4. PubMed ID: 2402738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.